Important Requirements for the Selection of Internal Standards during the Development of Desorption/Ionization Assays for Drug Quantification in Biological Matrices-A Practical Example.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
21 Jan 2022
Historique:
received: 21 12 2021
revised: 07 01 2022
accepted: 18 01 2022
entrez: 15 2 2022
pubmed: 16 2 2022
medline: 23 2 2022
Statut: epublish

Résumé

Desorption/ionization mass spectrometry (DI-MS) approaches allow for the rapid quantification of drugs in biological matrices using assays that can be validated according to regulatory guidelines. However, specific adaptations must be applied to create reliable quantification methods, depending on the approach and instrumentation used. In the present article, we demonstrate the importance of the molecular weight, the fragmentation pattern, and the purity of the internal standard for the development of matrix-assisted laser desorption/ionization (MALDI)-ion mobility (IM)-tandem MS and MS/MS methods. We present preliminary results of method development for the quantification of selinexor in microdialysis fluids with a stable isotopically labeled internal standard. In addition, we discuss the selection of internal standards for MALDI-MS assays using different instrumentations.

Identifiants

pubmed: 35163955
pii: molecules27030690
doi: 10.3390/molecules27030690
pmc: PMC8838468
pii:
doi:

Substances chimiques

Pharmaceutical Preparations 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : SFB 1389

Références

Rapid Commun Mass Spectrom. 2020 Mar 30;34(6):e8614
pubmed: 31657865
Drug Test Anal. 2016 Feb;8(2):208-13
pubmed: 25922056
Mass Spectrom Rev. 2019 May;38(3):291-320
pubmed: 30707468
Anal Bioanal Chem. 2004 Mar;378(5):1322-6
pubmed: 14747894
Cancers (Basel). 2020 Jul 14;12(7):
pubmed: 32674434
Anal Chem. 2021 May 18;93(19):7152-7163
pubmed: 33914512
PLoS One. 2010 Jul 01;5(7):e11409
pubmed: 20625386
Bioanalysis. 2011 Jun;3(12):1369-78
pubmed: 21679031
J Am Soc Mass Spectrom. 2018 Jul;29(7):1456-1462
pubmed: 29633224
J Am Soc Mass Spectrom. 2020 Mar 4;31(3):742-751
pubmed: 31971791
Molecules. 2021 Feb 26;26(5):
pubmed: 33652935
J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Jun 30;1176:122781
pubmed: 34051651
Curr Opin Biotechnol. 2019 Feb;55:51-59
pubmed: 30153614
J Pharm Biomed Anal. 2015 Feb;105:107-114
pubmed: 25546027

Auteurs

Margaux Fresnais (M)

Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.

Seda Karabulut (S)

Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.

Yasmin Abou Zeed (Y)

Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.

Johannes Ungermann (J)

Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.

Julia Benzel (J)

Hopp Children's Cancer Center Heidelberg (KiTZ), Im Neuenheimer Feld 430, 69120 Heidelberg, Germany.
German Cancer Research Center (DKFZ), Division of Pediatric Neurooncology, German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.

Kristian W Pajtler (KW)

Hopp Children's Cancer Center Heidelberg (KiTZ), Im Neuenheimer Feld 430, 69120 Heidelberg, Germany.
German Cancer Research Center (DKFZ), Division of Pediatric Neurooncology, German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
Department of Pediatric Hematology, Oncology and Immunology, Heidelberg University Hospital, 69120 Heidelberg, Germany.

Stefan M Pfister (SM)

Hopp Children's Cancer Center Heidelberg (KiTZ), Im Neuenheimer Feld 430, 69120 Heidelberg, Germany.
German Cancer Research Center (DKFZ), Division of Pediatric Neurooncology, German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
Department of Pediatric Hematology, Oncology and Immunology, Heidelberg University Hospital, 69120 Heidelberg, Germany.

Walter E Haefeli (WE)

Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.

Jürgen Burhenne (J)

Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.

Rémi Longuespée (R)

Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.

Articles similaires

Humans Pharmaceutical Preparations Drug Utilization Prescription Drugs
Vibrio Whole Genome Sequencing Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization Genome, Bacterial Water Microbiology
Cicer Germination Proteolysis Seeds Plant Proteins
Humans Pisum sativum Breast Neoplasms Tandem Mass Spectrometry Plant Extracts

Classifications MeSH